David Russler-Germain, MD PhD
Fellow Recruitment Leader
|Hometown: Potomac, Maryland|
|Medical School: Washington University in St. Louis|
|Residency: Washington University in St. Louis/Barnes-Jewish Hospital|
|Research/Academic Interests: Follicular lymphoma, DLBCL, AML, cancer genomics, circulating tumor DNA, bispecific antibodies|
|Bio: I am the proud husband of a WashU pathology resident, and father of a 4.5 year old boy and newborn girl. In addition to my family and work, I love cooking, cycling, and photography. My family likes to spend weekends finding new paths and creeks to explore. We have a pool and love to BBQ for groups, including current and future fellows.|
- Russler-Germain DA and Kahl BS. “Recent Advances in Antibody Drug Conjugates for Lymphoma.” Oncology (Williston Park). 2020. Vol. 34, Issue 12. Pg. 522 – 534.
- Russler-Germain DA, Watkins MP, and Bartlett NL. “A forgotten friend: CCNU as palliative monotherapy in relapsed Hodgkin lymphoma.” Leukemia & Lymphoma. 2020. Vol. 62, Issue 2. Pg. 486 – 488.
- Russler-Germain DA, Fraum TJ, Watkins MP, and Bartlett NL. “Apparent appendicitis in Amyand hernia with unexpected pathology.” Int. J. of Case Rep. Images. 2019. Vol. 10:101030Z01DG2019.
- Cole CB, Russler-Germain DA, Ketkar S*, Verdoni AM, Smith AM, Bangert CV, Helton NM, Guo M, Klco JM, O’Laughlin S, Fronick C, Fulton R, Chang GS, Petti AA, Miller CA, and Ley TJ. “Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.” J. of Clin. Invest. 2017. Vol. 127, Issue 10. Pg. 3657 – 3674.
- Spencer DH, Russler-Germain DA, Ketkar S, Helton NM, Lamprecht TL, Fulton RS, Fronick CC, O’Laughlin M, Heath SE, Shinawi M, Westervelt P, Payton JE, Wartman LD, Welch JS, Wilson RK, Walter MJ, Link DC, DiPersio JF, and Ley TJ. “CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.” Cell. 2017. Vol. 168, Issue 5. Pg. 801 – 816.
- Matis M, Russler-Germain DA, Hu Q, Tomlin CJ, and Axelrod JD. “Microtubules provide directional information for core PCP function.” eLife. 2014. 10.7554/eLife.02893.
- Russler-Germain DA, Spencer DH, Young MA, Lamprecht TL, Miller CA, Fulton R, Meyer MR, Erdmann- Gilmore P, Townsend RR, Wilson RK, and Ley TJ. “The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers.” Cancer Cell. 2014. Vol. 25, Pg. 442 – 454.